Bellevue Life Sciences Acquisition Corp. (BLAC)
Bellevue Life Sciences Acquisition Corp. operates in the Shell Companies industry of the Financial Services sector, headquartered in Bellevue, WA, US. The stock last traded at $3.01, down 55.27% on the session, giving a market capitalisation of $7.0M. On trailing twelve-month figures it carries a trailing P/E of 1.23, a net margin of 301.5%. Its beta of 0.53 implies it has historically moved less than the broad market.
Bellevue Life Sciences Acquisition Corp. currently does not engage in substantial operational activities. Its core mission is to orchestrate a business combination, which could manifest as a merger, share exchange, asset acquisition, stock purchase, recapitalization, or reorganization, with one or more enterprises or organizations within the healthcare domain. This firm, established in 2020, maintains its principal office in Bellevue, Washington, and operates as a subordinate entity of Bellevue Global Life Sciences Investors LLC.
Bellevue Life Sciences Acquisition Corp. is most often compared with the following Financial Services names: